Story type: Institute
-
Better treatments sooner – Hudson’s new RNAte Platform unveiled
Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.… Read more
-
Hudson Institute welcomes inflammation specialist as new Centre Head
Hudson Institute’s world leading inflammation programs enter a new era with the appointment of Professor Seth Masters to lead the Centre for Innate Immunity and Infectious Diseases (CiiiD).… Read more
-
When stomach cancer survivor becomes expert
Despite encountering more than her share of health challenges, 92-year-old Delva Walker has the most positive outlook you are ever likely to encounter.… Read more
-
Hudson News: Summer 2023
Director’s Message: Changing the odds on ovarian cancer. As medical researchers, we spend a lot of our time looking at numbers, establishing which changes or effects are significant and which are not.… Read more
-
Hudson CEO appointed AAMRI President
Hudson Institute has cemented its position among Australia’s medical research leaders, with Director and CEO, Professor Elizabeth Hartland becoming President of the peak industry body.… Read more
-
Hudson News Winter 2023
Director’s message: For children with cancer, change starts here. Childhood cancer is rare but devastating and new treatment options are desperately needed. In the last four decades the US Food and Drug Authority (FDA) has approved 500 drugs for adult cancers but just 12 to treat childhood cancers.… Read more
-
Professor Elizabeth Hartland appointed AAMRI President Elect
Hudson Institute’s Director and CEO, Professor Elizabeth Hartland, has been appointed the President Elect for the Association of Australian Medical Research Institutes (AAMRI). Professor Hartland will advance from her current roles as a member of the Board and the Chair of the Victorian branch of AAMRI, to take on the national leadership as President in 2023.… Read more
-
State-of-the art genomic sequencer accelerates inflammation research
Hudson Institute of Medical Research is progressing its genomic and inflammation research with the acquisition of an Illumina NextSeq 2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.… Read more
-
Hudson Institute welcomes US cancer researcher as centre head
Hudson Institute has welcomed its newest head of the Centre for Cancer Research, Associate Professor Ron Firestein, who has relocated from San Francisco with his young family to take up the role.… Read more